Overview A Study of DER 45-EV Gel to Treat Rosacea Status: Completed Trial end date: 2013-01-01 Target enrollment: Participant gender: Summary To identify lowest efficacious dose of DER 45 EV Gel, 1% and 5% verses vehicle in patients with rosacea. Phase: Phase 2 Details Lead Sponsor: Sol-Gel Technologies, Ltd.